Four drug companies in settlement talks with states to resolve claims about their role in the opioid epidemic are poised to receive about $1 billion each in tax breaks if they finalized a combined payout totaling more than $26 billion, The Wall Street Journal reported Feb. 12.
The companies are Johnson & Johnson, McKesson, AmerisourceBergen and Cardinal Health.
Below are the amounts the companies both expect to pay as part of the settlement and receive as a tax benefit, according to regulatory filings.
- McKesson expects to pay $8.1 billion and receive $1.4 billion.
- AmerisourceBergen expects to pay $6.6 billion and receive $1.1 billion.
- Cardinal Health expects to pay $6.6 billion and receive $943 million.
- Johnson & Johnson Expects to pay $5 billion and receive $1 billion.